Events
-
ENDO 2026: Women’s thyroid cancer risk may be linked to reproductive lifespan and hormone therapy
-
ASCO 2026: Lancet Commission predict shortfall of 100 million cancer care workers by 2050
-
ASCO 2026: CAPTURE trial delivers learnings for metastatic breast cancer treatment
-
ASCO 2026: Teclistamab extends survival, deepens remissions in relapsed multiple myeloma
-
ASCO 2026: Lancet Commission predict shortfall of 100 million cancer care workers by 2050
-
-
ASCO 2026: Teclistamab extends survival, deepens remissions in relapsed multiple myeloma
-
-
-
Precision medicine becomes more accessible for Australians with cancer
A new resource developed at the Garvan Institute of Medical Research and The Kinghorn Cancer…
Leopard gecko skin tumours traced to cancer gene
The leopard gecko’s name was Mr. Frosty, and he was hard to miss. Yellow bands…
First Australian clinical trial to study COVID-19 vaccines in patients with all cancers
In an Australian first, Cancer Australia has launched the SerOzNET study, a large Australian clinical trial…
Cancer patients who tell their life story find more peace, less depression
Fifteen years ago, University of Wisconsin–Madison researcher Meg Wise began interviewing cancer patients nearing the end of life about how…
JOIN THE ONCOLOGY NETWORK
If you would like even more free news articles, access to our exclusive HCP only content including the latest podcasts from The Oncology Podcast and our Industry Partner Podcasts (including links to all papers and show notes), along with all our other resources, head over to The Oncology Network and sign up - FREE forever for HCPs only.